Drug Trial Radar · NCT06278948
Efficacy and Tolerability of Test Product Versus Cysteamine 5% in Treatment of Facial Epidermal Melasma
Last checked: Nov 19, 2026Latest source record: Feb 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
140
Planned (sponsor's estimate)
Start
Oct 6, 2023
Primary completion
Jun 2024
Study completion Jun 2024
Sponsor
- Lead sponsor
- Cosmetique Active InternationalIndustry
- Sponsor type
- Industry
- First posted
- Feb 26, 2024
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 20 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This interventional, randomized, investigator blinded, controlled study conducted in one centre consists in a 4-month evaluation period within the same season avoiding sunny season on 140 subjects with facial epidermal melasma.
Conditions
- Melasma
Interventions
Group TPOther
Application full face, twice daily, in the morning and at bedtime for 4 months
Group CYSDrug
Application short contact, of thin layer once daily at bedtime for 4 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- change in mMASI scoringTime frame: from baseline to Day112
- change in Investigator's Global Assessment (IGA)Time frame: from baseline to Day112
Locations
1 site in 1 country. Site status is shown where the registry gives one.
MS Clinical Research Pvt. Ltd
Bangalore, India · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.